Larimar Therapeutics Inc — Cash Flow (NASDAQ:LRMR) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics

Quarterly Annual

Cash from operating activities -42.2 M-42.1 M-27.57 M-33.46 M-70.76 M-113.2 M -113.05 M Cash from investing activities 17.09 M24.17 M-90.96 M33.35 M-85.39 M100.31 M 100.31 M Cash from financing activities 93.59 M19.89 M75.26 M30 K161.88 M65.09 M — Free cash flow -42.26 M-42.44 M-27.67 M-33.62 M-71.28 M-113.29 M -113.14 M

Haberler

2 Companies Tackling the AI Bottlenecks

William Blair, Larimar Therapeutics hissesi için görüşünü yineledi

Guggenheim, Larimar için Al tavsiyesini yineledi, 26 dolar hedefi korudu

2 Breakout Stocks to Buy Immediately

LRMR Stock on the Move: What Sparked the 55% Jump in the Past Month?

Wedbush, Larimar Therapeutics hisse hedefini 12 dolara yükseltti

Wedbush raises Larimar Therapeutics stock price target to $12

Larimar Therapeutics: Deerfield kuruluşları 25 milyon dolarlık hisse aldı

Larimar Therapeutics: Deerfield entities buy $25m in stock

Larimar Therapeutics hisseleri 100 milyon dolarlık halka arzda %8 düştü

Larimar Therapeutics stock falls 8% on upsized $100 million offering

Larimar Therapeutics 100 milyon dolarlık hisse arzını duyurdu